State of Wisconsin Investment Board’s Mineralys Therapeutics MLYS Stock Holding History

State of Wisconsin Investment Board’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Buy	73,265 +9,127	+14%	+$250K	﹤0.01%	1492
2026 Q1	$1.74M	Buy	64,138 +14,197	+28%	+$416K	﹤0.01%	1456
2025 Q4	$1.81M	Buy	49,941 +23,015	+85%	+$923K	﹤0.01%	1452
2025 Q3	$1.02M	Buy	26,926 +2,375	+10%	+$51.4K	﹤0.01%	1613
2025 Q2	$332K	Buy	24,551 +14,297	+139%	+$207K	﹤0.01%	2027
2025 Q1	$163K	Buy	+10,254	New	+$118K	﹤0.01%	2126

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State of Wisconsin Investment Board's MLYS Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Mineralys Therapeutics (MLYS) stake by 14% in Q2 2026, buying an estimated $250K and bringing the position to 73,265 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

State of Wisconsin Investment Board first reported a position in MLYS in Q1 2025 and has held it in 6 quarters since. 224 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

State of Wisconsin Investment Board held 73,265 shares of Mineralys Therapeutics worth $1.98M as of Q2 2026.
State of Wisconsin Investment Board bought 9,127 Mineralys Therapeutics shares in Q2 2026, an estimated $250K.
Mineralys Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1492 holding.
State of Wisconsin Investment Board first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 6 quarters since.
224 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.